ConductScience.org, home

Library / Trial comparisons

Chlorhexidine Cord Care vs Dry Cord Care: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.01520.01360.0171wilsonClinicalTrials.gov
Risk in group 20.01360.01210.0153wilsonClinicalTrials.gov
Risk difference, group 1 minus group 20.00164-0.0007620.00406newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 21.120.9491.32logClinicalTrials.gov
Odds ratio, group 1 over group 21.120.9481.33logClinicalTrials.gov
Number needed to harm, for one more death from any cause on Chlorhexidine Cord Care than on Dry Cord Care610from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Chlorhexidine Cord Care
Mothers located in health facility catchment areas assigned to this arm will apply chlorhexidine to their infants daily until three days after the cord completely separates.~Chlorhexidine gluconate (4%): Chlorhexidine is a topical antiseptic that has long been tested for safety and widely used in developed country hospitals, pre-surgical antiseptic technique, wound cleaning and disinfection. Mothers will be instructed to apply 10 ml of 4% chlorhexidine once a day following the infants bath every day from birth until three days after the cord completely separates from the infant's body.
28218,510EG000ClinicalTrials.gov
Group 2Dry Cord Care
Mothers in health facility catchment areas assigned to this arm will use dry cord care - keeping their babies' umbilical stumps clean and dry - as per normal routine standard of care and in accordance with Zambia Ministry of Health policy.~Dry cord care: Mothers will be instructed to keep their infants' umbilical cord stumps clean and dry and to not apply any foreign substances to the cord stump.
26319,346EG001ClinicalTrials.gov

Harm 2

FieldValueSource
What it countsTotal, all-cause mortalityClinicalTrials.gov
Time frameAdverse event data were collected during the 1 month follow up period past delivery.ClinicalTrials.gov

Trial 8

FieldValueSource
TitleZambia Chlorhexidine Application TrialClinicalTrials.gov
NCT numberNCT01241318ClinicalTrials.gov
PhasesPHASE2, PHASE3ClinicalTrials.gov
ConditionsSepsisClinicalTrials.gov
InterventionsChlorhexidine gluconate (4%), Dry cord careClinicalTrials.gov
Lead sponsorBoston UniversityClinicalTrials.gov
Results first posted2019-05-03ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT01241318?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.